News
Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.
The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...
Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...
The drug nearly eliminated HIV's spread among people who received an injection every six months. But some experts worry about how accessible it will be.
The Food and Drug Administration has just approved a preventative HIV drug widely regarded as a breakthrough. On Wednesday afternoon, the FDA approved Gilead Sciences’ lenacapavir as a more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results